Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1997 1
1998 1
1999 1
2003 1
2004 1
2005 1
2006 2
2007 1
2010 1
2011 1
2012 1
2013 1
2014 1
2015 1
2021 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Extended Reality in Neurosurgical Education: A Systematic Review.
Iop A, El-Hajj VG, Gharios M, de Giorgio A, Monetti FM, Edström E, Elmi-Terander A, Romero M. Iop A, et al. Sensors (Basel). 2022 Aug 14;22(16):6067. doi: 10.3390/s22166067. Sensors (Basel). 2022. PMID: 36015828 Free PMC article. Review.
Extended reality in cranial and spinal neurosurgery - a bibliometric analysis.
Buwaider A, El-Hajj VG, Mahdi OA, Iop A, Gharios M, de Giorgio A, Romero M, Gerdhem P, Jean WC, Edström E, Elmi-Terander A. Buwaider A, et al. Among authors: iop a. Acta Neurochir (Wien). 2024 Apr 25;166(1):194. doi: 10.1007/s00701-024-06072-4. Acta Neurochir (Wien). 2024. PMID: 38662229 Free PMC article. Review.
Cisplatin and gemcitabine in non-small-cell lung cancer.
Cartei G, Sacco C, Sibau A, Pella N, Iop A, Tabaro G. Cartei G, et al. Among authors: iop a. Ann Oncol. 1999;10 Suppl 5:S57-62. doi: 10.1093/annonc/10.suppl_5.s57. Ann Oncol. 1999. PMID: 10582141 Free article. Review.
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.
Rosati G, Lonardi S, Galli F, Di Bartolomeo M, Ronzoni M, Zampino MG, Banzi M, Zaniboni A, Pasini F, Bozzarelli S, Garattini SK, Ferrari D, Montesarchio V, Mambrini A, Ciuffreda L, Galli F, Pusceddu V, Carlomagno C, Bidoli P, Amoroso D, Bochicchio AM, Frassineti L, Corsi D, Bilancia D, Pastorino A, De Stefano A, Labianca R; TOSCA (Three or Six Colon Adjuvant) investigators. Rosati G, et al. Eur J Cancer. 2021 May;148:190-201. doi: 10.1016/j.ejca.2021.01.051. Epub 2021 Mar 18. Eur J Cancer. 2021. PMID: 33744715
Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).
Di Costanzo F, Carlini P, Doni L, Massidda B, Mattioli R, Iop A, Barletta E, Moscetti L, Recchia F, Tralongo P, Gasperoni S. Di Costanzo F, et al. Among authors: iop a. Br J Cancer. 2005 Jul 25;93(2):185-9. doi: 10.1038/sj.bjc.6602640. Br J Cancer. 2005. PMID: 15986036 Free PMC article. Clinical Trial.
18 results